Cited by 12Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

The longest ever randomised controlled trial of insulin glargine: study design and HbA1c findings

Open access
Currie, C. J.·2009·Diabetologia

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-009-1477-6

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Most of these studies had very few cancer cases among users of sulfonylureas, so power was limited to examine associations with specific cancer sites.

    “However, most of these studies had very few cancer cases among users of sulfonylureas, and therefore power was limited to examine associations with specific cancer sites (91,111).”

    From Diabetes and Cancer (2010) · cites this paper as [111]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Currie, C. J.
Affiliations
Cardiff University (GB)
Corresponding author
Currie, C. J.
Venue
Diabetologia
Published
2009-08-07
Volume
52
Issue
10
Pages
2234-2235
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W1973844122
Cited by
12
References
5
Citations by year
2020: 1 · 2017: 2 · 2016: 1 · 2014: 1 · 2013: 1
FWCI
1.46
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
insulin glargine, long-acting insulin, type 1 diabetes, HbA1c, glycemic control, insulin therapy, research design
MeSH terms
Insulin Glargine, Diabetes Mellitus, Type 2, Diabetic Retinopathy, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Randomized Controlled Trials as Topic, Insulin, Long-Acting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review